Figure 2.

The disease-free survival (DFS) of patients, grouped by apoptotic cell rates. The survival of patients with primary tumours presenting high AIs (lower line) is significantly shorter than the survival of patients presenting tumours with low AIs (upper line).

Alcaide et al. BMC Clinical Pathology 2013 13:24   doi:10.1186/1472-6890-13-24
Download authors' original image